CM Hospitalar S/A (BVMF:VVEO3)
Brazil · Delayed Price · Currency is BRL 1.840
+0.100 (5.75%)
At close: Apr 22, 2026
CM Hospitalar S/A Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,567 | 11,583 | 11,084 | 8,747 | 6,219 | |
Revenue Growth (YoY) | -0.14% | 4.51% | 26.72% | 40.65% | 40.91% |
Cost of Revenue | 9,898 | 10,277 | 9,349 | 7,350 | 5,121 |
Gross Profit | 1,669 | 1,306 | 1,735 | 1,397 | 1,097 |
Selling, General & Admin | 1,327 | 1,473 | 1,146 | 863.53 | 671.86 |
Other Operating Expenses | -213.54 | 537.62 | -41.01 | 10.28 | -71.19 |
Operating Expenses | 1,140 | 2,121 | 1,097 | 879.77 | 602.01 |
Operating Income | 528.89 | -814.99 | 638.13 | 516.89 | 495.3 |
Interest Expense | -590.9 | -489.45 | -660.37 | - | -386.75 |
Interest & Investment Income | 70.89 | 91.12 | 162.42 | - | 303.31 |
Earnings From Equity Investments | -1 | -11.86 | -1.68 | -3.53 | -3 |
Currency Exchange Gain (Loss) | 21.11 | -54.93 | - | - | - |
Other Non Operating Income (Expenses) | 12.92 | -275.31 | - | -305.28 | - |
EBT Excluding Unusual Items | 41.9 | -1,555 | 138.5 | 208.08 | 408.85 |
Asset Writedown | -5.58 | -45.58 | - | - | - |
Legal Settlements | 9.36 | 9.44 | - | - | - |
Pretax Income | 45.67 | -1,592 | 138.5 | 208.08 | 408.85 |
Income Tax Expense | 27.44 | -176.06 | -221.42 | -51.65 | 13.7 |
Earnings From Continuing Operations | 18.24 | -1,415 | 359.92 | 259.73 | 395.16 |
Net Income | 18.24 | -1,415 | 359.92 | 259.73 | 395.16 |
Net Income to Common | 18.24 | -1,415 | 359.92 | 259.73 | 395.16 |
Net Income Growth | - | - | 38.57% | -34.27% | 224.52% |
Shares Outstanding (Basic) | 316 | 318 | 300 | 284 | 262 |
Shares Outstanding (Diluted) | 316 | 318 | 300 | 284 | 262 |
Shares Change (YoY) | -0.59% | 5.88% | 5.74% | 8.48% | 16.35% |
EPS (Basic) | 0.06 | -4.46 | 1.20 | 0.92 | 1.51 |
EPS (Diluted) | 0.06 | -4.46 | 1.20 | 0.92 | 1.51 |
EPS Growth | - | - | 31.05% | -39.41% | 178.91% |
Free Cash Flow | 231.09 | -47.47 | -1,064 | 380.51 | 242.16 |
Free Cash Flow Per Share | 0.73 | -0.15 | -3.54 | 1.34 | 0.93 |
Dividend Per Share | - | - | 0.137 | 0.277 | 0.405 |
Dividend Growth | - | - | -50.69% | -31.57% | - |
Gross Margin | 14.43% | 11.27% | 15.65% | 15.97% | 17.64% |
Operating Margin | 4.57% | -7.04% | 5.76% | 5.91% | 7.96% |
Profit Margin | 0.16% | -12.22% | 3.25% | 2.97% | 6.35% |
Free Cash Flow Margin | 2.00% | -0.41% | -9.60% | 4.35% | 3.89% |
EBITDA | 632.22 | -621.21 | 898.74 | 693.25 | 593.49 |
EBITDA Margin | 5.47% | -5.36% | 8.11% | 7.93% | 9.54% |
D&A For EBITDA | 103.33 | 193.77 | 260.61 | 176.36 | 98.19 |
EBIT | 528.89 | -814.99 | 638.13 | 516.89 | 495.3 |
EBIT Margin | 4.57% | -7.04% | 5.76% | 5.91% | 7.96% |
Effective Tax Rate | 60.07% | - | - | - | 3.35% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.